|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
||||||||
| TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 04/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Adventitious Presence (Low-Level Presence)
U.S. Low-Level Presence Policy
Funding for the USDA
H.J. RES. 48: 6th Continuing Resolution for FY 2011
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
Biomass Crop Assistance Program (BCAP)
EPA Regulations on Agricultural Biotechnology
Livestock Cloning/Product Labeling
Genetically-Engineered (GE) Animals
Labeling
FDA Approval
Export Registrations for Products with Expired Patents
Labeling of Genetically-Engineered Crops
U.S. Government Policy
U.S. Policy on International Science-Based Regulations
U.S. Position within Organization for Economic Cooperation and Development (OECD)
TransPacific Partnership
Funding for the USDA
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Foreign Agricultural Biotechnology Laws and Regulations
APEC Agricultural Biotechnology Discussions
China Biotechnology Regulations
Discussions with EU on Animal Cloning
EU Biotechnology Bilateral Discussions
European Union Low-Level Presence Policy
International Biotechnology Agreement
Low-Level Presence Foreign Government Policies
Regulatory Actions on Biological Pesticides
H.R. 872: Reducing Regulatory Burdens Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), State - Dept of (DOS), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Patrick |
Carroll |
|
|
|
Matthew |
O'Mara |
|
|
|
David |
Edwards |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
|
Tracey |
LaTurner |
|
Professional Staff, Committee on Approp. |
|
Tracey |
LaTurner |
|
Scheduler, Rep. Jim Bunn |
|
Tracey |
LaTurner |
|
Internship, Rep. Bill Paxton |
|
Tracey |
LaTurner |
|
Internship, NRCC |
|
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Genetically-Engineered (GE) Animals
Labeling
FDA Approval
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Science & Technology Policy (OSTP), U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
DelMonte |
DelMonte |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health
H.R. 1: Full-Year Continuing Appropriations Act for FY 2011
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels, Foreign Agriculture Service)
H.J. RES.48: 6th Continuing Resolution for FY 2011
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
H.R. 1: Full-Year Continuing Appropriations Act for FY 2011
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure)
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Funding for Bio-based Products
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Funding for Biofuels
H.J. RES. 48: 6th Continuing Resolution for FY 2011
DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Patrick |
Carroll |
|
|
|
Matt |
Carr |
|
|
|
Phyllis |
Arthur |
|
|
|
Melissa |
Bowie |
|
|
|
Andrew |
Emmett |
|
|
|
David |
Edwards |
|
|
|
Cartier |
Esham |
|
|
|
Jeanne |
Haggerty |
|
|
|
Paul |
Poteet |
|
|
|
Sara |
Radcliffe |
|
|
|
Anna |
Weinstein |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
|
Tracey |
LaTurner |
|
Professional Staff, Committee on Approp. |
|
Tracey |
LaTurner |
|
Scheduler, Rep. Jim Bunn |
|
Tracey |
LaTurner |
|
Internship, Rep. Bill Paxton |
|
Tracey |
LaTurner |
|
Internship, NRCC |
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
Regulatory Actions on Biological Pesticides
H.R. 872: Reducing Regulatory Burdens Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Matt |
Carr |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Patent Reform
S. 23: The Patent Reform Act of 2011/ H.R. 1249: The America Invents Act of 2011
World Trade Organization Special 301 Submissions
PTO Administrative Reforms
Genetic Resource Patent Disclosure Requirement
DNA Patenting and Licensing
Bayh-Dole Act/Tech Transfer
Amicus Matters
Bayh-Dole Act/Tech Transfer
Intellectual Property International Enforcement
Patent Presumption of Validity
Amicus Matters
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Commerce - Dept of (DOC), Intl Trade Administration (ITA), Natl Institute of Standards & Technology (NIST), Patent & Trademark Office (PTO), State - Dept of (DOS), Treasury - Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lila |
Feisee |
|
|
|
Hans |
Sauer |
|
|
|
Matthew |
Schumaker |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Tom |
DiLenge |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Funding for FDA
H.J. RES. 48: 6th Continuing Resolution for FY 2011
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
Livestock Cloning/Product Labeling
Genetically-Engineered (GE) Animals
Labeling
FDA Approval
Labeling of Genetically-Engineered (GE) Crops
U.S. Government Policy
Drug Shortages
S. 296: Preserving Access to Life-Savings Medicines Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Council on Environmental Quality (CEQ), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), State - Dept of (DOS), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Anna |
Weinstein |
|
|
|
Sara |
Radcliffe |
|
|
|
Melissa |
Bowie |
|
|
|
Patrick |
Carroll |
|
|
|
Jeanne |
Haggerty |
|
|
|
Matthew |
O'Mara |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
Biofuels
Biofuels Production Tax Credit Modification for Algae-based Biofuels
Biofuels Production Tax Credit Extension
Economic Growth Impact/Potential of Advanced Biofuels
Next Generation Incentives: Farm Bill Reauthorization
Funding for Biofuels
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Investment Tax Credit Options
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
Renewable Fuels Standard
Bio-based Products
Expansion of DOE and USDA Loan Guarantee Programs
Next Generation Incentives: Farm Bill Reauthorization
Tax Credit
Funding for Bio-based Products
H.J. RES. 48: 6th Continuing Resolution for FY 2011
USDA BioPreferred Program
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), U.S. HOUSE OF REPRESENTATIVES, Energy - Dept of, Agriculture - Dept of (USDA), Defense - Dept of (DOD), Navy - Dept of, Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Education - Dept of, Natl Economic Council (NEC), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Patrick |
Carroll |
|
|
|
Paul |
Poteet |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
|
Tracey |
LaTurner |
|
Professional Staff, Committee on Approp. |
|
Tracey |
LaTurner |
|
Scheduler, Rep. Jim Bunn |
|
Tracey |
LaTurner |
|
Internship, Rep. Bill Paxton |
|
Tracey |
LaTurner |
|
Internship, NRCC |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Genetically-Engineered (GE) Animals
Labeling
FDA Approval
Livestock Cloning/Product Labeling
Labeling of Genetically-Engineered (GE) Crops
U.S. Government Policy
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), Agriculture - Dept of (USDA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
Biofuels
Biofuels Production Tax Credit Modification for Algae-based Biofuels
Biofuels Production Tax Credit Extension
Economic Growth Impact/Potential of Advanced Biofuels
Next Generation Incentives: Farm Bill Reauthorization
Funding for Biofuels
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Investment Tax Credit Options
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
Renewable Fuels Standard
Bio-based Products
Expansion of DOE and USDA Loan Guarantee Programs
Next Generation Incentives: Farm Bill Reauthorization
Tax Credit
Funding for Bio-based Products
H.J. RES. 48: 6th Continuing Resolution for FY 2011
USDA BioPreferred Program
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Energy - Dept of, Agriculture - Dept of (USDA), Defense - Dept of (DOD), Navy - Dept of, Natl Economic Council (NEC), Council on Environmental Quality (CEQ), Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Paul |
Poteet |
|
|
|
Patrick |
Carroll |
|
|
|
Paul |
Poteet |
|
|
|
Brent |
DelMonte |
|
|
|
Tracey |
LaTurner |
|
Professional Staff, Committee on Approp. |
|
Tracey |
LaTurner |
|
Scheduler, Rep. Jim Bunn |
|
Tracey |
LaTurner |
|
Internship, Rep. Bill Paxton |
|
Tracey |
LaTurner |
|
Internship, NRCC |
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Biosimilars
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Funding for National Institutes of Health
H.R. 1: Full-Year Continuing Appropriations Act for FY 2011
Vaccine Access/Financing
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Diagnostics and Personalized Medicine Regulation and Oversight
Therapeutic Discovery Project Tax Credit
Extension
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Drug Safety and Review
Prescription Drug User Fee Act (PDUFA) Reauthorization
Critical Path Initiative
Funding for FDA
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Independent Payment Advisory Board
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
H.R. 1: Full-Year Continuing Appropriations Act for FY 2011
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Pharmaceutical Industry Annual Fee
Treasury and IRS Regulations Implementing the Law
Biodefense Research, Development and Procurement
HHS Countermeasures Review
Drug Shortages
S. 296: Preserving Access to Life-Savings Medicines Act of 2011
17. House(s) of Congress and Federal agencies Check if None
Internal Revenue Service (IRS), Treasury - Dept of, Natl Security Council (NSC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Food & Drug Administration (FDA), Government Accountability Office (GAO), Centers For Disease Control & Prevention (CDC), Agency for Health Care Policy & Research, Defense - Dept of (DOD), Executive Office of the President (EOP), Office of Management & Budget (OMB), Office of the Secretary of Defense
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shelly |
Mui-Lipnik |
|
|
|
Paul |
Poteet |
|
|
|
Patrick |
Carroll |
|
|
|
Andrew |
Emmett |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Brent |
DelMonte |
|
|
|
Tracey |
LaTurner |
|
Professional Staff, Committee on Approp. |
|
Tracey |
LaTurner |
|
Scheduler, Rep. Jim Bunn |
|
Tracey |
LaTurner |
|
Internship, Rep. Bill Paxton |
|
Tracey |
LaTurner |
|
Internship, NRCC |
|
Tom |
DiLenge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
H.R. 1: Full-Year Continuing Appropriations Act for FY 2011
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Biodefense Research, Development and Procurement
HHS Countermeasures Review
17. House(s) of Congress and Federal agencies Check if None
Natl Security Council (NSC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Defense - Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Office of the Secretary of Defense, Centers For Disease Control & Prevention (CDC), Government Accountability Office (GAO), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melissa |
Bowie |
|
|
|
Anna |
Weinstein |
|
|
|
Phyllis |
Arthur |
|
|
|
Matthew |
Schumaker |
|
|
|
Patrick |
Carroll |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
DelMonte |
|
|
|
Tracey |
LaTurner |
|
Professional Staff, Committee on Approp. |
|
Tracey |
LaTurner |
|
Scheduler, Rep. Jim Bunn |
|
Tracey |
LaTurner |
|
Internship, Rep. Bill Paxton |
|
Tracey |
LaTurner |
|
Internship, NRCC |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Funding for National Institutes of Health
H.R. 1: Full-Year Continuing Appropriations Act for FY 2011
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
H.R. 1: Full-Year Continuing Appropriations Act for FY 2011
H.J. RES. 48: 6th Continuing Resolution for FY 2011
Biodefense Research, Development and Procurement
HHS Countermeasures Review
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Defense - Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), Office of the Secretary of Defense, Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Phyllis |
Arthur |
|
|
|
Patrick |
Carroll |
|
|
|
Tracey |
LaTurner |
|
Professional Staff, Committee on Approp. |
|
Tracey |
LaTurner |
|
Scheduler, Rep. Jim Bunn |
|
Tracey |
LaTurner |
|
Internship, Rep. Bill Paxton |
|
Tracey |
LaTurner |
|
Internship, NRCC |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Independent Payment Advisory Board
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Melissa |
Bowie |
|
|
|
Jeanne |
Haggerty |
|
|
|
Anna |
Weinstein |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Small Business Innovation and Research (SBIR) Program Reauthorization
S.493: SBIR/STTR Reauthorization Act of 2011
Research & Development Tax Credit Extension
H.R. 942: American Research and Competitiveness Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Paul |
Poteet |
|
|
|
Alan |
Eisenberg |
|
|
|
Matthew |
Schumaker |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Small Business Innovation and Research (SBIR) Program Reauthorization
S.493: SBIR/STTR Reauthorization Act of 2011
Sarbanes Oxley Section 404 (b) Exemption
Therapeutic Discovery Project Tax Credit
Extension
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of, Securities & Exchange Commission (SEC),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Paul |
Poteet |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Tooshar |
Swain |
|
|
|
Brent |
DelMonte |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Bio-based Products
Tax Credit
Therapeutic Discovery Project Tax Credit
Extension
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Biofuels
Biofuels Production Tax Credit Modification for Algae-based Biofuels
Biofuels Production Tax Credit Extension
Investment Tax Credit Options
Research & Development Tax Credit Extension
H.R. 942: American Research and Competitiveness Act of 2011
Pharmaceutical Industry Annual Fee
Treasury and IRS Regulations Implementing the Law
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of, Agriculture - Dept of (USDA), Defense - Dept of (DOD), Energy - Dept of, Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Education - Dept of, Environmental Protection Agency (EPA), Natl Economic Council (NEC), Navy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Paul |
Poteet |
|
|
|
Matthew |
Schumaker |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Livestock Cloning/Product Labeling
World Trade Organization Special 301 Submissions
Export Registrations for Products with Expired Patents
U.S. Policy on International Science-Based Regulations
U.S. Position within Organization for Economic Cooperation and Development (OECD)
Intellectual Property International Enforcement
TransPacific Partnership
Foreign Agricultural Biotechnology Laws and Regulations
APEC Agricultural Biotechnology Discussions
China Biotechnology Regulations
Discussions with EU on Animal Cloning
EU Biotechnology Bilateral Discussions
European Union Low-Level Presence Policy
International Biotechnology Agreement
Low-Level Presence Foreign Government Policies
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), State - Dept of (DOS), Commerce - Dept of (DOC), Patent & Trademark Office (PTO), Intl Trade Administration (ITA), Treasury - Dept of, U.S. Customs & Border Protection
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Matthew |
OMara |
|
|
|
Lila |
Feisee |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
Legislative Director, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Legislative Correspondent, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Staff Assistant, Rep. Ike Skelton |
|
Dana |
O'Brien |
|
Internship, Rep. Ike Skelton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Drug Shortages
S. 296: Preserving Access to Life-Savings Medicines Act of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melissa |
Bowie |
|
|
|
Matthew |
Schumaker |
|
|
|
Anna |
Weinstein |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |